Bringing the fundamentals into focus…
Back to Design Therapeutics, Inc.
How Design Therapeutics, Inc. stacks up
DSGN · against 480 other Healthcare companies of similar size
Profitability
19/ 100
Near the bottom of its peers.
Ranked #393 of 481 · scores higher than 17% of peers
Bars: peers in each 10-point band of the profitability score46 peers with a profitability score of 10–19, including DSGN · Click a bar to see the companies
Why profitability scores 19?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 87% of peers. Return on assets: -32.9% vs peer median 1.7%
- a lower return on invested capital: weaker than 84% of peers. Return on invested capital: -33.2% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = DSGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DSGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 455 reported | -33.2% | 2.7% | 15% | 33% | |
| Operating marginHigher is better · 451 reported | Not reported | 4.8% | — | — | 33% |
| Return on assetsHigher is better · 476 reported | -32.9% | 1.0% | 12% | 33% | |
| Return on equityHigher is better · 456 reported | -34.1% | 1.6% | 19% | Context only | |
| Gross marginHigher is better · 497 reported | 0.0% | 42.5% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around DSGN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 387 | 486M USD | 21 | 16 | |
| 387 | 375M USD | 21 | 46 | |
| 392 | 646M USD | 20 | 46 | |
| 393 | 815M USD | 19 | 53 | |
| 393 | 647M USD | 19 | 40 | |
| 393 | 441M USD | 19 | 34 | |
| 393 | 758M USD | 19 | 35 | |
| 393 | 1.2B USD | 19 | 40 | |
| 393 | 522M USD | 19 | 12 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score